This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (568) JMIR Theme Issue: COVID-19 Special Issue (2452) Outbreak and Pandemic Preparedness and Management (1728) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1517) Infectious Diseases (non-STD/STI) (1575) Medication Adherence (84) Doctor-Patient Communication on Cancer, Prevention, and Screening (42) Personal Health Records, Patient-Accessible Electronic Health Records, Patient Portals (573) Patient-Reported Outcome Measures (PROMs) (288)

Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25271, first published .
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

Authors of this article:

Fabio Efficace1 Author Orcid Image ;   Massimo Breccia2 Author Orcid Image ;   Paola Fazi1 Author Orcid Image ;   Francesco Cottone1 Author Orcid Image ;   Bernhard Holzner3, 4 Author Orcid Image ;   Marco Vignetti1 Author Orcid Image
Article Authors Cited by (4) Tweetations (5) Metrics

Fabio Efficace   1 , PhD ;   Massimo Breccia   2 , MD ;   Paola Fazi   1 , MD ;   Francesco Cottone   1 , PhD ;   Bernhard Holzner   3, 4 , PhD ;   Marco Vignetti   1 , MD

1 Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy

2 Department of Precision and Translational Medicine, Sapienza University, Rome, Italy

3 University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria

4 Evaluation Software Development Ltd, Innsbruck, Austria

Corresponding Author:

  • Fabio Efficace, PhD
  • Data Center and Health Outcomes Research Unit
  • Italian Group for Adult Haematologic Diseases (GIMEMA)
  • via Casilina 5
  • Rome, 00182
  • Italy
  • Phone: 39 06441639831
  • Fax: 39 064402516
  • Email: f.efficace@gimema.it